The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
|Recipient||Amount||Start Date||End Date|
|First Flight Venture Center, Inc.||$ 98,314||   ||2018-06-01||2023-05-31|
|New Orleans Bioinnovation Center, Inc.||$ 88,405||   ||2018-06-01||2023-05-31|
|University City Science Center||$ 100,000||   ||2018-06-01||2023-05-31|
|Texas Medical Center||$ 96,500||   ||2018-06-01||2023-05-31|
|Medtech Innovator||$ 100,000||   ||2018-06-01||2023-05-31|
|University Of Massachusetts||$ 99,999||   ||2018-06-01||2023-05-31|
|Life Science Washington Institute||$ 99,998||   ||2018-06-01||2023-05-31|
|Research Foundation For The State University Of New York, The||$ 100,000||   ||2018-06-01||2023-05-31|
|Trustees Of Boston University||$ 110,000,000||   ||2016-08-01||2021-07-31|
|Trustees Of Boston University||$ 30,000,000||   ||2016-08-01||2021-07-31|
Fiscal Year 2009: No Current Data Available Fiscal Year 2010: It is anticipated that 20 applications will be received and 12 awards will be issued in fiscal year 2010. Fiscal Year 2011: No Current Data Available
Uses and Use Restrictions
Support international in-country advanced development and industrialization of human pandemic influenza vaccine.
Support activities related to the mitigation of the global shortage of influenza vaccines through awards and sub-awards to developing countries with the potential and capacity to manufacture various influenza vaccines.
Basic research (e.g.
scientific or medical experiments) is not allowable.
100% of funds are for discretionary activities.
All types of entities are eligible, including highly qualified foreign nationals outside the United States either alone or in collaboration with American participants when such transactions may inure to the benefit of the American people.
Applicants should review the individual funding opportunity announcements issued under this CFDA program.
All individuals including at-risk individuals such as children, pregnant women, elderly, and others at-risk who may be given special priority.
Applicants should review the individual funding opportunity announcements issued under this CFDA program for any credentials or certifications that must be submitted prior to or simultaneous with submission of an application package. OMB Circular No. A-87 applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. Grant applications and required forms for this program can be obtained through Grants.gov - FIND, http://www.grants.gov/. Applicants should visit Grants.gov - FIND for the funding opportunity announcement and Grants.gov - APPLY to download application materials to complete and submit their applications in accordance with the funding opportunity announcement (FOA).
Applications that successfully proceed through initial screening (as outlined in the funding opportunity announcement) will be objectively reviewed based upon the review criteria specified in the FOA. Applications selected for funding will be processed and the applicant notified in writing through the issuance of a Notice of Award from the Office of the Assistant Secretary for Preparedness and Response.
Sep 30, 2010: Applicable deadlines and due dates are specified in each funding opportunity announcement.
Public Health Service Act, Title III, Section 319L, as amended by Pandemic and All-Hazards Preparedness Act of 2006, Public Law 109-417; Consolidated Appropriations Act, 2010, Division D-Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010.
Range of Approval/Disapproval Time
From 90 to 120 days.
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Project periods are limited up to 60 months. Budget periods are limited up to 12 months. See the following for information on how assistance is awarded/released: Awardee is issued a Notice of Award, a legal document that informs the awardee that a grant award has been made. Awardee may draw down funds in advance of the incursion of an expenditure (up to three days) from the Payment Management System.
Post Assistance Requirements
Program reports are not applicable.
Recipients must report cash transaction data via the Payment Management System (PMS) using the cash transaction data elements captured on the Federal Financial Report (FFR), Standard Form (SF) 425.
Recipients will utilize the "Transactions" section of SF425 in lieu of the SF272.
The FFR SF425 cash Transaction Report is due 30 days after the end of each calendar quarter.
Grantees are required to submit semi-annual Program Progress Reports as well as final Program Progress Reports.
Report formats and submission requirements are outlined in the funding opportunity announcement.
ASPR requires cumulative financial reporting through consecutive funding periods on the SF269 FSR long form.
The FFR SF425 was designed to replace the Financial Status Report SF269 and the Federal Cash Transactions Report SF272 with one comprehensive financial reporting form.
Until HHS fully migrates to the SF425 FFR, recipients are still required to submit the SF269 Financial Status Report (FSR) semi-annually within 30 days after the first 6 month period and within 90 days of the budget period end date.
Grantees are required to submit final Financial Status Reports (SF-269).
Performance monitoring of awardees is completed by BARDA program staff.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.
Records must be kept available for 3 years after submission of the final expenditure report.
(Project Grants (Cooperative Agreements)) FY 09 $15,000,000; FY 10 est $16,000,000; FY 11 est $16,000,000
Range and Average of Financial Assistance
$250,000 to $2,000,000.
Regulations, Guidelines, and Literature
Public Law 109-417, 45 CFR 92, 45 CFR 74, 45 CFR 46, 2 CFR, HHS Grants Policy Statement found at http://www.hhs.gov/asrt/og/grantinformation/hhsgps107.pdf
Regional or Local Office
Michael L. Perdue, Biomedical Advanced Research and Development Authority, 330 Independence Ave SW, Room G-640, Washington, District of Columbia 20201 Email: Michael.Perdue@hhs.gov Phone: (202) 260-0966.
Criteria for Selecting Proposals
Discretionary awards are subject to objective review. Reviewers will individually evaluate and score applications based upon the review criteria specified in the funding opportunity announcement. Scored applications will be ordinally ranked. The highest ranked applications will receive priority consideration for award within available funding.